“Bicalutamide-Mediated Inhibition of Androgen Receptor Signaling and Its Effect on the Invasion and Migration of Ovarian Cancer Cells” (2026) New Journal of Biology and Medicine, 2(2), pp. 21–29. doi:10.64354/968ny790.